ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01XA05 | B | Oritavancin (diphosphate) - 400mg | 12232 | 120324/1 | ORBACTIV | 400mg | 3 | Injectable powder for concentrate for solution + solvent | Infusion | Droguerie R. Pharaon & Fils S.A.L. | Patheon Italia SpA, Italy under licensed from Melinta Therapeutics, Inc, Illinois, USA | Italy | 157,078,205 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 02/09/20 |